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Case description
A 7-year-old neutered male Siamese cat was presented 
to a university referral hospital in Scotland for weight 
loss and hyporexia of 1 month’s duration, as well as 
hypercalcaemia (3.3 mmol/l; reference interval [RI] 
2–3 mmol/l) detected by the referring veterinarian. 
Defaecation, thirst and urination were normal. The cat 
was fed a good-quality commercial diet, and routine 
vaccinations and prevention against external and inter-
nal parasites were up to date. It was an indoor/outdoor 
cat and an avid hunter (Figure 1), with no travel history 
outside of Scotland. On physical examination, the cat 
had harsh lung sounds with a normal respiratory rate 
(25 breaths/min) and effort; the remainder of the physi-
cal examination, including a retinal examination, was 
unremarkable.
Differential diagnoses for hypercalcemia included 
granulomatous disease,1,2 neoplasia,3,4 hypervitami-
nosis D,5 renal disease,3,6 primary hyperparathy-
roidism,3,7 idiopathic hypercalcaemia,8 osteolysis3 or 
hypoadrenocorticism.3,9 Weight loss could be caused 
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Abstract
Case summary A 7-year-old neutered male Siamese cat was referred for investigation of weight loss and 
hypercalcaemia (3.3 mmol/l; reference interval 2–3 mmol/l). Haematology, serum biochemistry, thoracic imaging, 
bronchoalveolar lavage (BAL), Ziehl–Neelsen staining of the BAL fluid and interferon gamma release assay (IGRA) 
were compatible with pneumonia caused by the less pathogenic member of the Mycobacterium tuberculosis 
complex, that is, M microti (the ‘vole bacillus’), which is common in cats in the UK. Treatment with azithromycin, 
rifampicin and marbofloxacin was given for 2 months, followed by 4 months of azithromycin and marbofloxacin. 
Treatment recommendations for tuberculous pneumonia have since changed. The cat remained asymptomatic for 
1 year but went on to develop M microti pneumonia on five other occasions, and was treated for 6–12 months on each 
occasion. The patient’s clinical signs, hypercalcaemia and radiographic/CT pulmonary pathology always resolved 
completely, and the IGRA became negative, before antimycobacterial treatment was stopped. This suggests cure 
followed by reinfection owing to avid hunting behaviour. Alternatively, this could represent recrudescence of dormant 
disease. This case has previously been included in a study that described a series of cases of feline tuberculosis.
Relevance and novel information This case shows that M microti infection in cats can present as recurrent episodes 
of pneumonia, even after prolonged treatment courses.
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by hyporexia, maldigestion, malabsorption, chronic 
infection or inflammation, renal or hepatic disease, 
neoplasia, cardiac or – less likely – endocrine disease, 
including hyperthyroidism (the cat was relatively 
young for this), diabetes mellitus (polyuria, polydip-
sia and polyphagia would be expected) or hypoadren-
ocorticism (rare in cats);10 underfeeding, poor-quality 
diet and oral disease had been excluded. Harsh lung 
sounds could indicate pneumonia, primary or meta-
static neoplasia or – less likely – idiopathic pulmonary 
fibrosis, pulmonary oedema or contusions. Hyporexia 
is a non-specific clinical sign; in the absence of oral/
nasal disease or environmental stress, hyporexia could 
indicate systemic disease, nausea or pain.
Haematology, serum biochemistry (including thyrox-
ine) and urine analysis were unremarkable, except for 
hypercalcaemia (ionised calcium [iCa] 1.75 mmol/l [RI 
1.1–1.35 mmol/l]; Table 1). Ionised hypercalcaemia was 
confirmed with a repeated blood sample, and there was 
no haemolysis or lipolysis. Feline immunodeficiency 
virus antibody and feline leukaemia virus antigen were 
negative, and blood pressure was normal.
Further investigations of hypercalcaemia (Table 2) 
included plasma parathyroid hormone concentration 
(<10 pg/ml [RI <40 pg/ml]; not supporting hyperpara-
thyroidism), plasma parathyroid hormone-related protein 
(<0.1 pmol/ml [RI <0.5 pmol/ml]; not supporting neopla-
sia, although there are other mechanisms by which neo-
plasia could result in hypercalcaemia), 25-hydroxyvitamin 
D (95 nmol/l [RI 127–335 nmol/l]; not supporting most 
types of hypervitaminosis D) and serum toxoplasma IgG 
and IgM titres (<50 and <20 [RI <50 and <20, respec-
tively]). Abdominal ultrasound and radiographs were 
unremarkable. Thoracic radiographs (Figure 2) revealed a 
diffuse, interstitial–alveolar pattern, most marked on the 
caudal lung lobes. Differential diagnoses included infec-
tious pneumonia (bacterial, parasitic, protozoal, viral or 
fungal), primary or metastatic neoplasia or, less likely, 
Figure 1 The 7-year-old neutered male Siamese cat, which 
has brought in a freshly hunted mouse to eat at its feeding 
station
Table 1 Haematology and serum biochemistry results at 
presentation to the referral hospital
Result RI
WBCs (×109/l) 7.3 7–20
Neutrophils (×109/l) 5.1 2.5–12.8
Monocytes (×109/l) 0.7 0.07–0.85
Eosinophils (×109/l) 1.5 1.5–7
Basophils (×109/l) 0 0–0.2
RBCs (×1012/l) 8.81 5.5–10
PCV (l/l) 0.45 0.24–0.45
Haemoglobin (g/dl) 13.9 8–14
MCV (fl) 51 39–55
MCHC (%) 30.9 30–36
Platelets (×109/l) 310 300–600
Total protein (g/dl) 69 69–79
Albumin (g/dl) 32.2 28–39
Globulin (g/dl) 36.8 23–50
ALT (U/l) 56 15–60
ALP (U/l) 78 10–100
Bile acids (µmol/l) 3.5 0–7
Bilirubin (µmol/l) 3.3 0–6.8
Urea (mmol/l) 10.2* 2.8–9.8
Creatinine (µmol/l) 142 40–177
Total calcium (mmol/l) 3.4* 2.1–2.5
Ionised calcium (mmol/l) 1.75* 1.1–1.35
Phosphate (mmol/l) 2.1 1.4–2.5
Sodium (mmol/l) 150 145–156
Potassium (mmol/l) 4.6 4–5
Chloride (mmol/l) 114 109–122
Glucose (mmol/l) 6.3* 3.3–5
*Abnormal finding
RI = reference interval; WBCs = white blood cells; RBCs = red 
blood cells; PCV = packed cell volume; MCV = mean cell volume; 
MCHC = mean cell haemoglobin concentration; ALT = alanine 
transaminase; ALP = alkaline phosphatase
Table 2 Plasma parathyroid hormone (PTH), parathyroid 




PTH (pg/ml) <10 <40
PTHrp (pmol/ml) <0.1 <0.5
25-hydroxyvitamin D (nmol/l) 95* 127–335
Toxoplasma IgG antibody titre by IFA <50 <50
Toxoplasma IgM antibody titre by IFA <20 <20
*Abnormal finding
IFA = immunofluorescence assay
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idiopathic pulmonary fibrosis. The spine and vertebrae 
were carefully examined in all radiographs for the pres-
ence of osteolytic lesions, and none were found.
The patient received treatment for possible lung-
worms (Advocate; Bayer) and underwent bronchoscopy. 
The airways appeared macroscopically normal; bron-
choalveolar lavage fluid (BALF) was sent for routine 
bacterial and fungal culture (which were negative), 
Mycoplasma felis PCR (this was negative) and cytology 
(which showed severe pyogranulomatous inflamma-
tion). In addition to routine haematoxylin and eosin 
staining, the BALF was stained with Grocott methena-
mine silver to evaluate the presence of fungi (negative) 
and Ziehl–Neelsen (ZN), which showed acid-fast bacilli 
morphologically consistent with mycobacterial infection. 
The interferon gamma release assay (IGRA) was per-
formed, and the results were compatible with infection 
by the less pathogenic member of the Mycobacterium 
tuberculosis complex (MTBC); that is, Mycobacterium 
microti (‘the vole bacillus’) (Figure 3).
Combining clinical signs and results, the patient was 
diagnosed with pneumonia and hypercalcaemia caused 
by M microti; that is, the cat had a form of tuberculosis 
commonly seen in cats in certain UK regions, including 
Scotland.13
The patient was treated with rifampicin (Rifadin 
[Sanofi]; 10 mg/kg PO q24h), azithromycin (Zithromax 
[Pfizer]; 15 mg/kg PO q24h) and marbofloxacin 
(Marbocyl P [Vetoquinol]; 3 mg/kg PO q24h) for 
2 months initially. A month after starting treatment, the 
cat’s body weight and appetite had improved, and iCa 
was normal. After 2 months of triple antibiotic therapy, 
haematology, serum biochemistry and thoracic radio-
graphs were unremarkable, and rifampicin was stopped. 
Figure 2 Dorsoventral (a) and right lateral thoracic (b) 
radiographs of the patient, showing a diffuse, interstitial–alveolar 
pattern, most marked on the caudal lung lobes
Figure 3 Interferon gamma release assay (IGRA) results. 
The response to bovine purified protein derivative (PPDB) 
indicates that the cat had a significant response to 
Mycobacterium tuberculosis complex (MTBC) bacteria; the 
response to avian purified protein derivative (PPDA) indicates 
that the cat had a weak immune response to members of 
the Mycobacterium avium complex (or this could be cross-
reactivity with MTBC). There was no response, however, to 
ESAT6/CFT10 peptides, which are present in pathogenic 
MTBC bacteria, including Mycobacterium bovis and M 
tuberculosis. Hence, these IGRA results are compatible 
with infection with a less pathogenic member of the MTBC, 
most likely Mycobacterium microti in the UK. While M bovis 
infection can on occasion give this picture, the cat had never 
been outside of Scotland, which is officially M bovis free11,12
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After an additional 4 months, iCa and thoracic radio-
graphs were unremarkable, IGRA was negative and 
serum vitamin D concentration was now normal, and so 
azithromycin and marbofloxacin were stopped.
The patient remained asymptomatic for 1 year but 
was infected with tuberculous pneumonia five more 
times – a total of six episodes over one decade (Figure 4). 
The cat was tested for retroviruses on several occasions 
and the results were always negative. The longest the 
cat was asymptomatic while not receiving treatment 
between episodes of tuberculous pneumonia was 2 years 
4 months. The cat always presented with weight loss, 
pneumonia, hypercalcaemia and an IGRA result com-
patible with M microti. In the initial infections, the cat 
was treated with triple antibiotic therapy (rifampicin, 
azithromycin and a fluoroquinolone – marbofloxacin or 
pradofloxacin) for a minimum of 2 months, then double 
therapy (azithromycin and a fluoroquinolone) for a 
minimum of 4 months. The last two episodes of tuber-
culous pneumonia were treated with triple antibiotic 
therapy for 6 and 11 months, including pradofloxacin 
(Veraflox [Bayer], 5 mg/kg PO q24h) and combined 
rifampicin/azithromycin capsules (Rifampicin 35 mg/
Azithromycin 30 mg Capsules [Bova Laboratories]; 
rifampicin 12 mg/kg PO q24h and azithromycin 10 mg/
kg PO q24h). All six episodes were treated for at least 
2 months beyond clinical resolution. The cat was moni-
tored throughout using an awake CT scan using the 
VetMouseTrap (University of Illinois). In addition to the 
six episodes of tuberculous pneumonia, the cat has had 
two episodes of presumptive M felis pneumonia (based 
on a negative IGRA and deep pharyngeal swab positive 
for M felis by PCR with a low cycle threshold number, 
hence significant infection; treated with pradofloxacin, 
dosed as above, for 2 months); at the time of writing, the 
cat has developed pulmonary fibrosis.
Discussion
The case reported here has been previously included in a 
study that described a series of cases of feline tuberculo-
sis;14 as the case is very unusual, we considered it impor-
tant to describe it in detail and document how it evolved.
Mycobacterial disease in cats is perhaps underdiag-
nosed in veterinary medicine worldwide. Tuberculosis 
in cats, which is caused by either M microti or M bovis, is 
seen most commonly in hunting adult male cats and 
usually presents with cutaneous lesions (two-thirds of 
cases) and/or submandibular lymphadenopathy (half 
of cases), presumably due to bites while playing with 
prey or wound contamination.13 Other presentations 
include dyspnoea due to pneumonia, and gastrointesti-
nal masses or abdominal lymphadenopathy, as reported 
recently in dozens of cats fed raw meat.11
Diagnosis of mycobacterial infection is often chal-
lenging. Apart from hypercalcaemia in some cases, the 
changes in haematology and serum biochemistry are 
non-specific, as they were in this case.15 Hypercalcaemia 
with granulomatous inflammation is due to local pro-
duction of 1,25-hydroxyvitamin D by macrophages.16 
Diagnostic imaging such as CT or radiography can be 
helpful in diagnosing mycobacterial infections in cats, 
although these can show a range of abnormalities and 
are not pathognomonic for mycobacterial infections.16,17 
The most striking abnormality in this patient was a dif-
fuse interstitial–alveolar pattern on thoracic radiographs, 
presumably resulting from haematogenous dissemina-
tion of mycobacteria.17,18 The ZN staining of the BALF 
confirmed mycobacterial disease in this case; however, it 
is important to note that a negative ZN stain is common 
in mycobacterial infection and does not rule it out.13 
Where possible, identification of mycobacteria species 
should be attempted by a combination of PCR, culture 
and/or IGRA, as different species have different zoonotic 
risks, different prognosis and respond differently to anti-
biotic therapy.
Culture should be attempted from surgically excised 
or biopsied tissue. If the disease is only seen in the lungs, 
as seen in this case, a minimum of 5 ml of BALF is needed 
for mycobacteria culture. Mycobacteria are often slow-
growing organisms, with certain species such as M microti 
requiring a minimum of 3 months to culture,18 and false-
negative results are seen in up to half of feline cases.13
PCR on tissue or BALF is currently often used to 
diagnose mycobacterial infection, with a specificity of 
around 100% and variable sensitivity.19 However, this 
was not available at the time of the first diagnosis. It is 
important to keep frozen unfixed tissue from biopsied 
lesions where mycobacterial infection is a differential 
diagnosis, as neither culture nor PCR can be performed 
on formalin-fixed tissue.
The IGRA uses specific mycobacterial proteins to stim-
ulate memory T cells in the blood ex vivo to determine if 
Figure 4 Timeline of the patient’s mycobacterial infections. The stars indicate when the presumptive Mycoplasma felis 
pneumonia episodes occurred. m = months; y = years
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a patient has been infected with an organism that pre-
sents these peptides. The test has been validated in cats 
and its sensitivity to detect mycobacteria from the MTBC 
(including M microti and M bovis) is 80–100%20,21 and its 
specificity is 93% (J Mitchell and DA Gunn-Moore, 
unpublished data 2020).
Finally, molecular epidemiology tests such as spoligo-
typing, mycobacterial interspersed repetitive unit varia-
ble number tandem repeat or, ideally, whole-genome 
sequencing, would add enormously to the understand-
ing of these cases. In particular, they would help to deter-
mine whether these cases are being continually re-infected 
from the environment (with different strains of mycobac-
teria), or whether it is more likely to be recrudescence (ie, 
the same strain); however, there could potentially be re-
infection with the same strain, depending on the diver-
sity of mycobacteria in the rodents the cats are hunting. 
For these molecular tests, extraction of DNA from cul-
tured material is required. We did not have cultured 
material, which we acknowledge as a limitation in this 
case report. We were unable to obtain enough BALF in 
the first presentation, and the owners declined repeat 
BALs during subsequent episodes owing to the need for 
general anaesthesia and the possible risks.
This patient had a total of six episodes of tuberculous 
pneumonia over a decade; on each occasion there was 
resolution of clinical signs, hypercalcaemia, lung changes 
on imaging and the IGRA became negative before treat-
ment was stopped. This is perhaps most suggestive of 
resolution of initial infection, followed by reinfection 
months to years later, due to avid hunting of infected 
mice and voles. Alternatively, this could represent recru-
descence of dormant disease. In human medicine, the 
duration between apparent ‘cure’ and ‘relapse’ helps to 
assess whether disease is more likely to be reinfection vs 
recrudescence, with periods of less than 1 year between 
episodes being much more likely in recrudescent cases;22 
it is not known whether this also applies to cats. A sim-
ple measure to prevent reinfection is to restrict the cats’ 
access to potential sources of reinfection, by keeping 
them indoors – this is the advice we give to all owners 
living in areas endemic for tuberculosis, but the owner of 
the cat reported here refused to do this.
It is possible that the cat’s negative IGRA (at the time 
of resolution of clinical signs) was a false-negative result; 
however, this result was always accompanied by resolu-
tion of the clinical signs, the hypercalcaemia and the 
imaging abnormalities. The negative predictive value of 
this test has been estimated to be 0.81 (95% confidence 
interval 0.64–0.91) (J Mitchell and DA Gunn-Moore, 
unpublished data 2020). More importantly, the IGRA 
remains positive in most cats treated for tuberculosis. 
This does not mean that those cats have been treated 
unsuccessfully, as they could be retaining primed mem-
ory T cells (J Mitchell and DA Gunn-Moore, unpublished 
data 2020). As in human medicine, the authors do not 
advise routine use of the IGRA for monitoring of disease 
resolution.
Of interest, the cat reported herein always showed the 
same presentation, with interstitial pneumonia being 
found on CT. This lung pattern is suggestive of haema-
togenous dissemination from a primary focus; however, 
no cutaneous lesion or peripheral lymphadenopathy 
were ever found in this case.
Previous recommendations for the treatment of 
tuberculosis in cats consisted of an initial phase of tri-
ple antibiotic therapy, followed by a continuation 
phase of double antibiotic therapy.13 There is limited 
evidence available on which to base optimal treatment; 
however, based on recommendations for people with 
tuberculosis, and experience gained treating feline 
mycobacterial infections for over 20 years, the authors 
now advise giving triple antibiotic therapy (rifampicin, 
azithromycin and pradofloxacin) for a minimum of 
6 months when there is pulmonary involvement, and 
for 2 months beyond complete clinical resolution. The 
combined rifampicin and azithromycin capsule (Bova 
UK Laboratories) helps with compliance when medi-
cating these cats. Side effects with rifampicin are com-
mon, and include hyporexia, vomiting, hepatopathy, 
hyperaesthesia, pruritus, erythema and skin discolour-
ation or oedema;23,24 premediating with chlorphena-
mine, and giving concurrent S-adenosylmethionine or 
N-acetylcysteine may reduce the cutaneous irritation 
and hepatopathy.25,26 The main side effects of azithro-
mycin are gastrointestinal and are uncommon.24,27 
Long courses of pradofloxacin can result in diarrhoea, 
and neutropenia has been reported with high doses 
and prolonged courses of pradofloxacin in dogs.28,29 
This patient was monitored for possible side effects by 
regular haematology and serum biochemistry, and 
given anti-nausea medication and hepato-protectants, 
as required.
Conclusions
This case shows that tuberculous pneumonia due to 
M microti infection in cats can be seen as multiple bouts 
of reinfection, or recrudescence, even after long courses 
of treatment.
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